Osvalds Pugovičs

1.5k total citations
39 papers, 1.2k citations indexed

About

Osvalds Pugovičs is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, Osvalds Pugovičs has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 18 papers in Clinical Biochemistry and 9 papers in Physiology. Recurrent topics in Osvalds Pugovičs's work include Metabolism and Genetic Disorders (18 papers), Metabolomics and Mass Spectrometry Studies (8 papers) and Diet and metabolism studies (8 papers). Osvalds Pugovičs is often cited by papers focused on Metabolism and Genetic Disorders (18 papers), Metabolomics and Mass Spectrometry Studies (8 papers) and Diet and metabolism studies (8 papers). Osvalds Pugovičs collaborates with scholars based in Latvia, Russia and Poland. Osvalds Pugovičs's co-authors include Maija Dambrova, Edgars Liepinsh, Solveiga Grı̄nberga, Janis Kuka, Marina Makrecka‐Kuka, Helena Cirule, Eduards Sevostjanovs, Ilze Konrāde, Dace Hartmane and Reinis Vilšķe̅rsts and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Osvalds Pugovičs

36 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Osvalds Pugovičs Latvia 20 720 415 271 95 92 39 1.2k
Solveiga Grı̄nberga Latvia 25 980 1.4× 574 1.4× 302 1.1× 118 1.2× 126 1.4× 89 1.7k
Reinis Vilšķe̅rsts Latvia 21 740 1.0× 373 0.9× 318 1.2× 154 1.6× 34 0.4× 45 1.4k
Janis Kuka Latvia 24 1.0k 1.4× 571 1.4× 434 1.6× 173 1.8× 96 1.0× 47 1.7k
Jean W. Hsu United States 20 528 0.7× 419 1.0× 186 0.7× 51 0.5× 81 0.9× 55 1.4k
Anthony J. DiDonato United States 7 952 1.3× 566 1.4× 72 0.3× 97 1.0× 143 1.6× 8 1.3k
Anurag Singh Switzerland 10 424 0.6× 316 0.8× 85 0.3× 81 0.9× 148 1.6× 19 1.4k
Mı́riam Martins Chaves Brazil 18 279 0.4× 159 0.4× 159 0.6× 29 0.3× 48 0.5× 61 1.0k
José García de la Asunción Spain 10 564 0.8× 228 0.5× 100 0.4× 31 0.3× 34 0.4× 15 1.2k
Lauri O. Byerley United States 23 534 0.7× 770 1.9× 77 0.3× 35 0.4× 137 1.5× 48 1.7k
Luigi Cardia Italy 17 276 0.4× 117 0.3× 151 0.6× 64 0.7× 96 1.0× 72 1.2k

Countries citing papers authored by Osvalds Pugovičs

Since Specialization
Citations

This map shows the geographic impact of Osvalds Pugovičs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osvalds Pugovičs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osvalds Pugovičs more than expected).

Fields of papers citing papers by Osvalds Pugovičs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osvalds Pugovičs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osvalds Pugovičs. The network helps show where Osvalds Pugovičs may publish in the future.

Co-authorship network of co-authors of Osvalds Pugovičs

This figure shows the co-authorship network connecting the top 25 collaborators of Osvalds Pugovičs. A scholar is included among the top collaborators of Osvalds Pugovičs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osvalds Pugovičs. Osvalds Pugovičs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Grı̄nberga, Solveiga, Eduards Sevostjanovs, Dace Bandere, et al.. (2021). LC-MS/MS method for simultaneous quantification of the first-line anti-tuberculosis drugs and six primary metabolites in patient plasma: Implications for therapeutic drug monitoring. Journal of Chromatography B. 1185. 122986–122986. 11 indexed citations
3.
Makrecka‐Kuka, Marina, et al.. (2020). Chemical composition of Prunus padus L. flower extract and its anti-inflammatory activities in primary bone marrow-derived macrophages. Journal of Ethnopharmacology. 268. 113678–113678. 9 indexed citations
4.
Olek, Robert A., Angelika K. Sawicka, Dace Hartmane, et al.. (2019). Increased Trimethylamine N-Oxide Is Not Associated with Oxidative Stress Markers in Healthy Aged Women. Oxidative Medicine and Cellular Longevity. 2019. 1–6. 22 indexed citations
5.
Sawicka, Angelika K., Dace Hartmane, Solveiga Grı̄nberga, et al.. (2018). L-Carnitine Supplementation Increases Trimethylamine-N-Oxide but not Markers of Atherosclerosis in Healthy Aged Women. Annals of Nutrition and Metabolism. 74(1). 11–17. 41 indexed citations
6.
Zaharenko, Linda, Ineta Kalniņa, Kristine Geldnere, et al.. (2016). Single nucleotide polymorphisms in the intergenic region between metformin transporter OCT2 and OCT3 coding genes are associated with short-term response to metformin monotherapy in type 2 diabetes mellitus patients. European Journal of Endocrinology. 175(6). 531–540. 25 indexed citations
7.
Liepinsh, Edgars, Marina Makrecka‐Kuka, Janis Kuka, et al.. (2014). Inhibition of L‐carnitine biosynthesis and transport by methyl‐γ‐butyrobetaine decreases fatty acid oxidation and protects against myocardial infarction. British Journal of Pharmacology. 172(5). 1319–1332. 35 indexed citations
8.
Tārs, Kaspars, Ja̅nis Leita̅ns, Andris Kazāks, et al.. (2014). Targeting Carnitine Biosynthesis: Discovery of New Inhibitors against γ-Butyrobetaine Hydroxylase. Journal of Medicinal Chemistry. 57(6). 2213–2236. 37 indexed citations
9.
Makrecka‐Kuka, Marina, Janis Kuka, Kristine Volska, et al.. (2014). Long-chain acylcarnitine content determines the pattern of energy metabolism in cardiac mitochondria. Molecular and Cellular Biochemistry. 395(1-2). 1–10. 47 indexed citations
10.
Kuka, Janis, Edgars Liepinsh, Marina Makrecka‐Kuka, et al.. (2014). Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation. Life Sciences. 117(2). 84–92. 75 indexed citations
11.
Liepinsh, Edgars, Marina Makrecka‐Kuka, Janis Kuka, et al.. (2013). The heart is better protected against myocardial infarction in the fed state compared to the fasted state. Metabolism. 63(1). 127–136. 56 indexed citations
12.
Makrecka‐Kuka, Marina, Baiba Švalbe, Kristine Volska, et al.. (2013). Mildronate, the inhibitor of l-carnitine transport, induces brain mitochondrial uncoupling and protects against anoxia-reoxygenation. European Journal of Pharmacology. 723. 55–61. 18 indexed citations
13.
Liepinsh, Edgars, Elina Skapare, Janis Kuka, et al.. (2013). Activated peroxisomal fatty acid metabolism improves cardiac recovery in ischemia-reperfusion. Naunyn-Schmiedeberg s Archives of Pharmacology. 386(6). 541–550. 43 indexed citations
14.
Liepinsh, Edgars, Elina Skapare, Edijs Vavers, et al.. (2012). High l-carnitine concentrations do not prevent late diabetic complications in type 1 and 2 diabetic patients. Nutrition Research. 32(5). 320–327. 8 indexed citations
15.
Kuka, Janis, Marina Makrecka‐Kuka, Solveiga Grı̄nberga, et al.. (2012). A short-term high-dose administration of sodium pivalate impairs pyruvate metabolism without affecting cardiac function. Cardiovascular Toxicology. 12(4). 298–303. 5 indexed citations
16.
Švalbe, Baiba, Liga Zvejniece, Edijs Vavers, et al.. (2011). Mildronate treatment improves functional recovery following middle cerebral artery occlusion in rats. Behavioural Brain Research. 222(1). 26–32. 31 indexed citations
17.
Jankevics, Andris, et al.. (2009). Metabolomic studies of Experimental Diabetic Urine Samples by 1H NMR Spectroscopy and LC/MS Method. publication.editionName. 11–17. 1 indexed citations
18.
Liepinsh, Edgars, Janis Kuka, Baiba Švalbe, et al.. (2009). Effects of Long‐Term Mildronate Treatment on Cardiac and Liver Functions in Rats. Basic & Clinical Pharmacology & Toxicology. 105(6). 387–394. 27 indexed citations
19.
Grı̄nberga, Solveiga, Liga Zvejniece, Edgars Liepinsh, Maija Dambrova, & Osvalds Pugovičs. (2008). Quantitative analysis of phenibut in rat brain tissue extracts by liquid chromatography–tandem mass spectrometry. Biomedical Chromatography. 22(12). 1321–1324. 6 indexed citations
20.
Liepinsh, Edgars, Reinis Vilšķe̅rsts, Elina Skapare, et al.. (2008). Mildronate decreases carnitine availability and up-regulates glucose uptake and related gene expression in the mouse heart. Life Sciences. 83(17-18). 613–619. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Solveiga Grı̄nberga Breakdown of academic impact, for papers by Reinis Vilšķe̅rsts Breakdown of academic impact, for papers by Janis Kuka Breakdown of academic impact, for papers by Jean W. Hsu Breakdown of academic impact, for papers by Anthony J. DiDonato Breakdown of academic impact, for papers by Anurag Singh Breakdown of academic impact, for papers by Mı́riam Martins Chaves Breakdown of academic impact, for papers by José García de la Asunción Breakdown of academic impact, for papers by Lauri O. Byerley Breakdown of academic impact, for papers by Luigi Cardia
Rankless by CCL
2026